Sage Journals: Discover world-class research

Open access

Research article

First published 2025-11

Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis

Tjalf Ziemssen, Mark S Freedman, Amit Bar-Or [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2008-06

Paradoxically aggressive multiple sclerosis in the face of natalizumab therapy

JR Berger

Multiple Sclerosis Journal

Retricted access

Research article

First published 2025-1

Safety,efficacy,and tolerability of alemtuzumab in pediatric patients with active relapsing-remitting multiple sclerosis: The LemKids study

Tanuja Chitnis, Douglas L Arnold, Pierre Quartier [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2022-7

Assessment of automatic decision-support systems for detecting active T2 lesions in multiple sclerosis patients

Alex Rovira, Juan Francisco Corral, Cristina Auger [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2021-1

Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study

Mark S Freedman, Patricia K Coyle, Giancarlo Comi [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2016-1

No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy

Alfredo Damasceno, Benito Pereira Damasceno, Fernando Cendes

Multiple Sclerosis Journal

Open access

Research article

First published 2022-4

Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial

Bianca Weinstock-Guttman, Robert Bermel, Gary Cutter [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2026-3

Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)—A meta-regression of randomized controlled trials

Roxanne Pretzsch, Sahla El Mahdaoui, Poljanka Johnson [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2023-10

Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension

Stephen L Hauser, Ronald Zielman, Ayan Das Gupta [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2009-10

Glatiramer acetate in combination with minocycline in patients with relapsing—remitting multiple sclerosis: results of a Canadian,multicenter,double-blind,placebo-controlled trial

LM Metz, D. Li, A. Traboulsee [...]

Multiple Sclerosis Journal

Search results